During the past decade, Kardiologie, Campus Mitte, Charite conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kardiologie, Campus Mitte, Charite" are "Coronary Restenosis" (2 trials). Many other conditions were trialed in "Kardiologie, Campus Mitte, Charite" in a lesser frequency.

Most popular intervention types in "Kardiologie, Campus Mitte, Charite" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel coated balloon catheter (device with drug)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kardiologie, Campus Mitte, Charite" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kardiologie, Campus Mitte, Charite". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kardiologie, Campus Mitte, Charite, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kardiologie, Campus Mitte, Charite, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".